Is It Time to Replace the Hamilton Depression Rating Scale as the Primary Outcome Measure in Treatment Studies of Depression?
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Department of Psychiatry and Human Behavior, Brown University School of Medicine, Rhode Island Hospital, Providence, RI. Address correspondence and reprint requests to Mark Zimmerman, MD, Bayside Medical Center, 235 Plain Street, Providence, RI 02905. E-mail: [email protected].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Wilamowska (2010) · doi:10.1001/archpsyc.1988.01800320058007 · Cited by 2,115
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959
Residual symptoms after partial remission: an important outcome in depression
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995) · Psychological Medicine · doi:10.1017/s0033291700033146 · Cited by 791 · cited 1×
“That is, responders who have not remitted are significantly more likely to relapse than responders who have remitted.(35,36) However, evidence from the Collaborative Depression Study indicates that the presence of mild residual symptoms confers an increased risk of relapse compared with asymptomatic patients, which is…”
ResultResidual symptoms in depressed patients who respond acutely to fluoxetine
Nierenberg, A. A., Keefe, B. R., Leslie, V. C., Alpert, J. E., Pava, J. A., Worthington, J. J., Rosenbaum, J. F., & Fava, M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0403 · Cited by 470 · cited 1×
“Because of this and because several diagnostic criteria for MDD are not included on the HRSD, a conceptual problem arises in that some patients simultaneously meet criteria for minor depression or MDD and also are considered to be in remission.(32,33) There is something wrong with an outcome tool, or the definition of…”
BackgroundJudd, L. L., Paulus, M. J., Schettler, P. J., Akiskal, H. S., Endicott, J., Leon, A. C., Maser, J. D., Mueller, T., Solomon, D. A., & Keller, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1501 · Cited by 458
Zung, Beck and Hamilton Rating Scales as measures of treatment outcome: a meta-analytic comparison.
Lambert, M. J., Hatch, D. R., Kingston, M. D., & Edwards, B. C. (1986) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.54.1.54 · Cited by 232 · cited 1×
“One repeated criticism of the HRSD has been that the vegetative symptoms of depression are overrepresented.(24) Longer versions of scale have included items assessing cognitive symptoms of depression such as worthlessness, hopelessness, and helplessness, although these versions are much less frequently used than the 1…”
MethodExactly what does the Hamilton depression rating scale measure?
Gibbons, R. D., Clark, D. C., & Kupfer, D. J. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90037-3 · Cited by 223
Relapse of major depression after complete and partial remission during a 2-year follow-up
Pintor, L. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00480-3 · Cited by 96
Symptom Severity and Exclusion From Antidepressant Efficacy Trials
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00011 · Cited by 49 · cited 1×
“Longer versions of scale have included items assessing cognitive symptoms of depression such as worthlessness, hopelessness, and helplessness, although these versions are much less frequently used than the 17- and 21-item versions.(25)”
MethodSelf-citation
Cited by
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009
Depression rating scales in Parkinson's disease: Critique and recommendations
Schrag, A., Barone, P., Brown, R. G., Leentjens, A. F. G., McDonald, W. M., Starkstein, S., Weintraub, D., Poewe, W., Rascol, O., Sampaio, C., et al. (2007) · Movement Disorders · doi:10.1002/mds.21333 · Cited by 683
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Mundt, J. C., Snyder, P. J., Cannizzaro, M. S., Chappie, K., & Geralts, D. S. (2007) · Journal of Neurolinguistics · doi:10.1016/j.jneuroling.2006.04.001 · Cited by 380
The GRID-HAMD: standardization of the Hamilton Depression Rating Scale
Williams, J. B. W., Kobak, K. A., Bech, P., Engelhardt, N., Evans, K., Lipsitz, J., Olin, J., Pearson, J., & Kalali, A. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f948f5 · Cited by 295
“Zimmerman has highlighted several advantages to the HAMD, such as its provision of long-term continuity in assessment methodology that allows comparison across decades of studies, and its ability to discriminate drug from placebo in clinical trials and to measure change (Zimmerman et al., 2005).”
Background
Metadata
- Authors
- Zimmerman, M., Posternak, M. A., & Chelminski, I.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2005-04
- Volume
- 25
- Issue
- 2
- Pages
- 105-110
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2015954404
- Cited by
- 58
- References
- 10
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is It Time to Replace the Hamilton Depression Rating Scale as the Primary Outcome Measure in Treatment Studies of Depression? https://app.cochat.ai/papers/10.1097/01.jcp.0000155824.59585.46
- The paper
- Zimmerman, M., Posternak, M. A., & Chelminski, I. (2005). Is It Time to Replace the Hamilton Depression Rating Scale as the Primary Outcome Measure in Treatment Studies of Depression? Journal of Clinical Psychopharmacology. https://doi.org/10.1097/01.jcp.0000155824.59585.46
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.